96
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Gender differences in dispensed analgesics in Sweden during 2006–2015 – an observational, nationwide, whole-population study

Pages 55-64 | Published online: 18 Jan 2018

References

  • WestermanSWengerNKWomen and heart disease, the underrecognized burden: sex differences, biases, and unmet clinical and research challengesClin Sci (Lond)2016130855156326957643
  • AppelmanYvan RijnBBTen HaafMEBoersmaEPetersSASex differences in cardiovascular risk factors and disease preventionAtherosclerosis2015241121121825670232
  • RaghavanDJainRIncreasing awareness of sex differences in airway diseasesRespirology201621344945926677803
  • Regitz-ZagrosekVSex and gender differences in health. Science & Society Series on Sex and ScienceEMBORep2012137596603
  • KuehnerCWhy is depression more common among women than among men?Lancet Psychiatry20174214615827856392
  • BuoncervelloMMarconiMCareAPiscopoPMalorniWMatarresePPreclinical models in the study of sex differencesClin Sci (Lond)2017131644946928265036
  • BaggioGCorsiniAFloreaniAGianniniSZagonelVGender medicine: a task for the third millenniumClin Chem Lab Med201351471372723515103
  • Regitz-ZagrosekVSeelandUSex and gender differences in clinical medicineHandb Exp Pharmacol2012214322
  • LoydDRMurphyAZPain and analgesiaSchenck-GustafssonKDeColaPRPfaffDWPisetskyDSHandbook of Clinical Gender MedicineBaselKarger2012183188
  • RosenSHamBMogilJSSex differences in neuroimmunity and painJ Neurosci Res2017951–250050827870397
  • SorgeRETotschSKSex differences in painJ Neurosci Res20179561271128127452349
  • MelchiorMPoisbeauPGaumondIMarchandSInsights into the mechanisms and the emergence of sex-differences in painNeuroscience2016338638027180284
  • AmandussonABlomqvistAEstrogenic influences in pain processingFront Neuroendocrinol201334432934923817054
  • BartleyEJFillingimRBSex differences in pain: a brief review of clinical and experimental findingsBr J Anaesth20131111525823794645
  • DoyleHHMurphyAZSex differences in innate immunity and its impact on opioid pharmacologyJ Neurosci Res2017951–248749927870418
  • EngelGLThe need for a new medical model: a challenge for biomedicineScience19771964286129136847460
  • Borrell-CarrioFSuchmanALEpsteinRMThe biopsychosocial model 25 years later: principles, practice, and scientific inquiryAnn Fam Med20042657658215576544
  • WainerJWainerZGender mattersSchenck-GustafssonKDeColaPRPfaffDWPisetskyDSHandbook of Clinical Gender MedicineBaselKarger201214
  • Fernandez-LizEModamioPCatalanALastraCFRodriguezTMarinoELIdentifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, SpainBr J Clin Pharmacol200865340741717922886
  • RoeCMMcNamaraAMMotheralBRGender- and age-related prescription drug use patternsAnn Pharmacother2002361303911816254
  • GlaeskeGGerdau-HeitmannCHofelFSchicktanzC“Gender-specific drug prescription in Germany” results from prescriptions analysesHandb Exp Pharmacol2012214149167
  • NishtalaPSOhSKimDChunNBinti KamisSFKiuKCAnalgesic medicine utilization in older people in New Zealand from 2005 to 2013Drugs Real World Outcomes20152217718527747769
  • ZhongWMaradit-KremersHSauverJLStAge and sex patterns of drug prescribing in a defined American populationMayo Clin Proc201388769770723790544
  • WHO Collaborating Centre for Drug Statistics Methodology Available from: http://www.whocc.no/Accessed February 04, 2017
  • WettermarkBHammarNForedCMThe new Swedish prescribed drug register opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiol Drug Saf200716772673516897791
  • WallerstedtSMWettermarkBHoffmannMThe first decade with the Swedish prescribed drug register – a systematic review of the output in the Scientific LiteratureBasic Clin Pharmacol Toxicol2016119546446927112967
  • FinnerupNBAttalNHaroutounianSPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisLancet Neurol201514216217325575710
  • SvendsenKBorchgrevinkPFredheimOHamunenKMellbyeADaleOChoosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily dosesPalliat Med201125772573221378066
  • VrijensBDe GeestSHughesDAABC Project TeamA new taxonomy for describing and defining adherence to medicationsBr J Clin Pharmacol201273569170522486599
  • LoikasDWettermarkBvon EulerMBergmanUSchenck-GustafssonKDifferences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in SwedenBMJ Open201335e002378
  • FolkhälsomyndighetenFolkhälsan i Sverige 2016HalmstadISY information system AB2016
  • DeColaPRGender effects on health and healthcareSchenck-GustafssonKDeColaPRPfaffDWPisetskyDSHandbook of Clinical Gender MedicineBaselKarger20121017
  • PereiraMPDonahueRRDahlJBWernerMTaylorBKWernerMUEndogenous opioid-masked latent pain sensitization: studies from mouse to humanPLoS One2015108e013444126305798
  • TajerianMSahbaiePSunYSex differences in a murine model of complex regional pain syndromeNeurobiol Learn Mem201512310010926070658
  • BaleTLEppersonCNSex differences and stress across the lifespanNat Neurosci201518101413142026404716
  • HuntKAdamsonJHewittCNazarethIDo women consult more than men? A review of gender and consultation for back pain and headacheJ Health Serv Res Policy201116210811720819913
  • ElnegaardSAndersenRSPedersenAFSelf-reported symptoms and healthcare seeking in the general population exploring “The Symptom Iceberg”BMC Public Health20151568526195232
  • SocialstyrelsenJämställd vård? Könsperspektiv på hälsooch sjukvården. SocialstyrelsenStockholmSwedish Board of Health and Welfare2004 Swedish
  • DeepmalaDFranzLAponteCAgrawalMJiangWIdentification of provider characteristics influencing prescription of analgesics: a systematic literature reviewPain Pract201313650451323157929
  • BäckrydEHeiligMHoffmannMDynamiken i forskrivningen av opioider i Sverige 2000–2015 – Markanta omfordelningar inom opioidgruppen, men ingen “epidemi” [Opioid prescription changes in Sweden 2000–2015]Lakartidningen2017114EFUE Swedish28485763
  • von EulerMKeshaniSBaatzKWettermarkBUtilization of trip-tans in Sweden; analyses of over the counter and prescription salesPharmacoepidemiol Drug Saf201423121288129325044442
  • FinocchiCStradaLSex-related differences in migraineNeurol Sci201435Suppl 120721324867868
  • Vargas-SchafferGIs the WHO analgesic ladder still valid? Twenty-four years of experienceCan Fam Physician2010566514517e202e20520547511
  • KrumholzHMRossJSPreslerAHEgilmanDSWhat have we learnt from Vioxx?BMJ2007334758512012317235089
  • MileradJLärdomar från coxibernas uppgång och fall [Lessons learned from the coxibs’ ups and downs. The journals must be tougher against referees and authors]Lakartidningen20081052115601561 Swedish18574991
  • QuanMHot topics in primary care: the cardiovascular safety of non-steroidal anti-inflammatory drugs: putting the evidence in perspectiveJ Fam Pract2017664 SupplS52S5728375409
  • ZhouYBoudreauDMFreedmanANTrends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. populationPharmacoepidemiol Drug Saf2014231435023723142
  • HakonsenHHedenrudTA population-based study of risk perceptions of paracetamol use among Swedes-with a special focus on young adultsPharmacoepidemiol Drug Saf201726899299728585409
  • GedeborgRSvennbladBHolmLIncreased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry studyPharmacoepidemiol Drug Saf201726551852728083980
  • HedenrudTHakonsenHPurchase habits, use of paracetamol, and information sources on a reregulated Swedish pharmacy market: a population-based studyHealth Policy20171211354127890394
  • European Medicines AgencyPRAC recommends modified-release paracetamol be removed from market Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Paracetamol-modified_release/human_referral_prac_000062.jsp&mid=WC0b01ac05805c516fAccessed October 24, 2017
  • SarganasGButteryAKZhuangWPrevalence, trends, patterns and associations of analgesic use in GermanyBMC Pharmacol Toxicol2015162826428626
  • SamuelsenPJSlordalLMathisenUDEggenAEAnalgesic use in a Norwegian general population: change over time and high-risk use – The Tromso StudyBMC Pharmacol Toxicol2015161626048167